Search Results - "Ryšavá, Romana"

Refine Results
  1. 1
  2. 2

    A novel dosing approach for rituximab in glomerular diseases based on a population pharmacokinetic analysis by Hartinger, Jan Miroslav, Šíma, Martin, Hrušková, Zdenka, Pilková, Alena, Krátký, Vojtěch, Ryšavá, Romana, Jančová, Eva, Bobek, Daniel, Douša, Jiří, Francová, Ivana, Tesař, Vladimír, Slanař, Ondřej

    Published in Biomedicine & pharmacotherapy (01-06-2024)
    “…Rituximab is being increasingly prescribed for the treatment of autoimmune glomerular diseases. While it is highly effective for some diseases, the response is…”
    Get full text
    Journal Article
  3. 3

    AL amyloidosis: advances in diagnostics and treatment by Ryšavá, Romana

    Published in Nephrology, dialysis, transplantation (01-09-2019)
    “…Abstract AL amyloidosis (light chain; previously also called primary amyloidosis) is a systemic disease characterized by an amyloid deposition process…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Assessment of renal function before contrast media injection: right decisions based on inaccurate estimates by Ptáčník, Václav, Zogala, David, Skibová, Daniela, Jiskrová, Hana, Trnka, Jiří, Tesař, Vladimír, Ryšavá, Romana, Šámal, Martin

    Published in European radiology (01-06-2019)
    “…Objectives Information on renal function required before specified radiological examinations with contrast agents is usually obtained through prediction…”
    Get full text
    Journal Article
  6. 6

    The coincidence of IgA nephropathy and Fabry disease by Maixnerová, Dita, Tesař, Vladimír, Ryšavá, Romana, Reiterová, Jana, Poupětová, Helena, Dvořáková, Lenka, Goláň, Lubor, Neprašová, Michaela, Kidorová, Jana, Merta, Miroslav, Honsová, Eva

    Published in BMC nephrology (11-01-2013)
    “…IgA nephropathy (IgAN) is the most common glomerulonephritis, which may also coexist with other diseases. We present two patients with an unusual coincidence…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Renal impairment in monoclonal gammopathies and multiple myeloma by Ryšavá, Romana

    Published in Časopis lékařů českých (2024)
    “…The incidence of monoclonal gammopathy (MG) increases with age. In individuals over 80 years of age, we can diagnose the presence of monoclonal immunoglobulin…”
    Get more information
    Journal Article
  9. 9

    New developments in anaemia treatment - erythropoietin versus prolyl hydroxylase inhibitors? by Ryšavá, Romana

    Published in Vnitřní lékar̆stvĭ (31-10-2022)
    “…Anaemia is a very common complication of chronic kidney disease (CKD) and renal failure. The view of the treatment of anaemia has changed considerably since…”
    Get more information
    Journal Article
  10. 10

    Renal failure in multiple myeloma and its treatment by Ryšavá, Romana

    Published in Vnitřní lékar̆stvĭ (03-11-2020)
    “…Renal failure is a serious complication of multiple myeloma, and up to 50% of patients with this most frequent haematological malignancy may develop some form…”
    Get more information
    Journal Article
  11. 11

    Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report by Rysava, Romana, Peiskerova, Martina, Tesar, Vladimir, Benes, Jan, Kment, Martin, Szilágyi, Ágnes, Csuka, Dorottya, Prohászka, Zoltán

    Published in Frontiers in immunology (28-09-2022)
    “…Atypical hemolytic uremic syndrome (aHUS), also called complement-mediated hemolytic uremic syndrome (CM-HUS), is a rare disease caused by dysregulation in the…”
    Get full text
    Journal Article
  12. 12

    Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease by Rysavá, Romana, Tesar, Vladimír, Merta, Miroslav

    Published in Blood pressure monitoring (01-08-2005)
    “…To assess the antihypertensive and antiproteinuric efficacy and safety of the angiotensin II type 1 receptor blocker telmisartan in patients with hypertension…”
    Get full text
    Journal Article
  13. 13

    Does renal function influence plasma levels of advanced glycation and oxidation protein products in patients with chronic rheumatic diseases complicated by secondary amyloidosis? by Rysavá, Romana, Kalousová, Marta, Zima, Tomás, Dostál, Ctibor, Merta, Miroslav, Tesar, Vladimír

    Published in Kidney & blood pressure research (01-01-2007)
    “…The aim of the study was to assess the contribution of carbonyl and oxidative stresses to the development of amyloidosis in patients suffering from chronic…”
    Get more information
    Journal Article
  14. 14
  15. 15

    FHR-5 Serum Levels and CFHR5 Genetic Variations in Patients With Immune Complex-Mediated Membranoproliferative Glomerulonephritis and C3-Glomerulopathy by Garam, Nóra, Cserhalmi, Marcell, Prohászka, Zoltán, Szilágyi, Ágnes, Veszeli, Nóra, Szabó, Edina, Uzonyi, Barbara, Iliás, Attila, Aigner, Christof, Schmidt, Alice, Gaggl, Martina, Sunder-Plassmann, Gere, Bajcsi, Dóra, Brunner, Jürgen, Dumfarth, Alexandra, Cejka, Daniel, Flaschberger, Stefan, Flögelova, Hana, Haris, Ágnes, Hartmann, Ágnes, Heilos, Andreas, Mueller, Thomas, Rusai, Krisztina, Arbeiter, Klaus, Hofer, Johannes, Jakab, Dániel, Sinkó, Mária, Szigeti, Erika, Bereczki, Csaba, Janko, Viktor, Kelen, Kata, Reusz, György S, Szabó, Attila J, Klenk, Nóra, Kóbor, Krisztina, Kojc, Nika, Knechtelsdorfer, Maarten, Laganovic, Mario, Lungu, Adrian Catalin, Meglic, Anamarija, Rus, Rina, Kersnik Levart, Tanja, Macioniene, Ernesta, Miglinas, Marius, Pawłowska, Anna, Stompór, Tomasz, Podracka, Ludmila, Rudnicki, Michael, Mayer, Gert, Rysava, Romana, Reiterova, Jana, Saraga, Marijan, Seeman, Tomáš, Zieg, Jakub, Sládková, Eva, Stajic, Natasa, Szabó, Tamás, Capitanescu, Andrei, Stancu, Simona, Tisljar, Miroslav, Galesic, Kresimir, Tislér, András, Vainumäe, Inga, Windpessl, Martin, Zaoral, Tomas, Zlatanova, Galia, Józsi, Mihály, Csuka, Dorottya

    Published in Frontiers in immunology (10-09-2021)
    “…Factor H-related protein 5 (FHR-5) is a member of the complement Factor H protein family. Due to the homology to Factor H, the main complement regulator of the…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Cardiac amyloidosis: A comprehensive review by Fikrle, Michal, Paleček, Tomáš, Kuchynka, Petr, Němeček, Eduard, Bauerová, Lenka, Straub, Jan, Ryšavá, Romana

    Published in Cor et vasa (English ed.) (01-02-2013)
    “…Abstract Cardiac amyloidosis is characterized by clinically significant extracellular amyloid infiltration of the heart that is usually, but not always,…”
    Get full text
    Journal Article
  18. 18

    Contemporary treatment of amyloid heart disease by Palecek, Tomas, Fikrle, Michal, Nemecek, Eduard, Bauerova, Lenka, Kuchynka, Petr, Louch, William E, Spicka, Ivan, Rysava, Romana

    Published in Current pharmaceutical design (01-01-2015)
    “…The amyloidoses represent a group of diseases characterized by extracellular deposition of abnormal protein, amyloid, which is formed by insoluble…”
    Get more information
    Journal Article
  19. 19

    AL amyloidosis with renal involvement by Rysavá, Romana

    Published in Kidney & blood pressure research (01-01-2007)
    “…Primary (AL amyloidosis) is a systemic disease characterized by an amyloid deposition process in many organs, with unsatisfactory survival of patients. The…”
    Get more information
    Journal Article
  20. 20

    Expert opinion on the cooperation of diabetologists and internists with nephrologists in the care of patients with chronic kidney diseases by Viklický, Ondřej, Ryšavá, Romana, Tesař, Vladimír, Rychlík, Ivan, Prázný, Martin, Češka, Richard, Haluzík, Martin

    Published in Vnitřní lékar̆stvĭ (31-10-2022)
    “…Chronic kidney disease (CKD) affects 10% of the population of developed countries and significantly affects the population health. In addition to the…”
    Get more information
    Journal Article